Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05587244 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

G7 Freedom Constrained Vivacit-E Liners

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Jun 25, 2025, no change to tracked fieldsv5-v6
  2. Study sites: 9 to 10v4
  3. Study sites: 1 to 9v3
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation Start date changed from estimate of Dec 2022 to May 8, 2023 · Study sites: 0 to 1v2 Show 2 more changesShow less
    • Start date changed from estimate of Dec 2022 to May 8, 2023
    • Study sites: 0 to 1
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Freedom Constrained Vivacit-E Acetabular Liners in primary and revision total hip arthroplasty.
Trial Details
NCT Number NCT05587244
Lead Sponsor Zimmer Biomet
Conditions Osteoarthritis, Hip, Rheumatoid Arthritis, Non-Union Fracture, Trochanteric Fractures, Femoral Neck Fractures, Avascular Necrosis, Dislocation, Hip
Enrollment 202 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov